InvestorsHub Logo
Followers 74
Posts 15839
Boards Moderated 0
Alias Born 04/26/2010

Re: ziploc_1 post# 119064

Friday, 12/15/2017 1:17:06 PM

Friday, December 15, 2017 1:17:06 PM

Post# of 424006

If the ITC does not cooperate, the next step for Amarin will be to sue DS for infringement of their more than 50 approved patents for Vascepa.




Zip, if ITC fails to act and FDA drags feet on declaring DS EE-EPA unapproved drugs, how exactly does AMRN sue DS makers for patent violations, especially if they're not making specific medical claims? Trying to think of an analogy for any other kind of product here but coming up blank.

The Thought Police: To censor and protect. Craig Bruce

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News